Individualised renal artery denervation improves blood pressure control in Kazakhstani patients with resistant hypertension.

Background: The prevalence of hypertension in Kazakhstan is high, and the majority of patients are not adequately controlled. Treatment with renal artery denervation (RAD) could represent a useful therapeutic option for a subset of patients in Kazakhstan with resistant hypertension.

Aim: To assess the impact of RAD in a cohort of patients from Kazakhstan with resistant hypertension.